$92.5 B

GILD Mkt cap, 14-Jun-2018

$5.1 B

Gilead Sciences Revenue Q1, 2018
Gilead Sciences Gross profit (Q1, 2018)4.1 B
Gilead Sciences Gross profit margin (Q1, 2018), %80.3%
Gilead Sciences Net income (Q1, 2018)1.5 B
Gilead Sciences EBIT (Q1, 2018)2.2 B
Gilead Sciences Cash, 31-Mar-20187.6 B
Gilead Sciences EV111.4 B

Gilead Sciences Revenue Breakdown

Embed Graph

Gilead Sciences revenue breakdown by geographic segment: 20.9% from Europe, 63.7% from United States, 8.3% from Japan and 7.1% from Other

Gilead Sciences Financials

Gilead Sciences Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

11.2 b24.9 b32.6 b30.4 b26.1 b

Revenue growth, %

122%31%(7%)

Cost of goods sold

2.9 b3.8 b4 b4.3 b4.4 b

Gross profit

8.3 b21.1 b28.6 b26.1 b21.7 b

Gross profit Margin, %

74%85%88%86%83%

R&D expense

3.7 b

General and administrative expense

3.9 b

Operating expense total

12 b

EBIT

4.5 b15.3 b22.2 b17.6 b14.1 b

EBIT margin, %

40%61%68%58%54%

Interest expense

306.9 m412 m688 m964 m1.1 b

Pre tax profit

4.2 b14.9 b21.7 b17.1 b13.5 b

Income tax expense

1.2 b2.8 b3.6 b3.6 b8.9 b

Net Income

3.1 b12.1 b18.1 b13.5 b4.6 b

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018

Revenue

2.8 b5 b6.5 b6 b7.6 b8.2 b8.3 b7.8 b7.8 b7.5 b6.5 b7.1 b5.1 b

Cost of goods sold

681.9 m813.2 m924.7 m987.3 m882 m998 m1.1 b1.2 b864 m1.1 b957 m1.1 b1 b

Gross profit

2.1 b4.2 b5.6 b5.1 b6.7 b7.2 b7.2 b6.6 b6.9 b6.4 b5.5 b6 b4.1 b

Gross profit Margin, %

75%84%86%84%88%88%87%85%89%85%85%84%80%

R&D expense

546.2 m595 m583.9 m630.5 m696 m818 m743 m1.3 b1.5 b1.1 b931 m864 m937 m

General and administrative expense

406.9 m548.1 m613.6 m944.8 m645 m812 m903 m685 m890 m831 m850 m897 m997 m

Operating expense total

1.6 b2 b2.1 b2.6 b2.2 b2.6 b2.7 b3.1 b3.2 b3.1 b2.7 b2.9 b2.9 b

EBIT

1.1 b3 b4.4 b3.5 b5.4 b5.6 b5.6 b4.7 b4.5 b4.4 b3.8 b4.3 b2.2 b

EBIT margin, %

41%61%68%58%71%68%67%60%58%59%58%60%42%

Interest expense

73.9 m76.3 m102 m103.4 m153 m140 m165 m230 m227 m242 m261 m269 m290 m

Pre tax profit

1.1 b2.9 b4.3 b3.4 b5.2 b5.5 b5.5 b4.5 b4.4 b4.3 b3.6 b4.1 b2 b

Income tax expense

294.5 m725.9 m656.6 m646.6 m907 m1 b880 m935 m902 m951 m918 m1 b494 m

Net Income

785.2 m2.2 b3.7 b2.7 b4.3 b4.5 b4.6 b3.6 b3.5 b3.3 b2.7 b3.1 b1.5 b

Gilead Sciences Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

2.1 b10 b12.9 b8.2 b7.6 b

Inventories

2.1 b1.4 b2 b1.6 b801 m

Current Assets

7.3 b17.7 b24.8 b20.4 b31.8 b

PP&E

1.2 b1.7 b2.3 b2.9 b3.3 b

Goodwill

1.2 b1.2 b1.2 b1.2 b4.2 b

Total Assets

22.5 b34.7 b51.8 b57 b70.3 b

Accounts Payable

1.3 b955 m1.2 b1.2 b814 m

Short-term debt

2.7 b483 m982 m

Current Liabilities

6.3 b5.8 b9.9 b9.2 b11.6 b

Long-term debt

3.9 b11.9 b21.1 b26.3 b30.8 b

Total Debt

6.6 b12.4 b22.1 b26.3 b30.8 b

Additional Paid-in Capital

5.4 b2.4 b444 m454 m1.3 b

Retained Earnings

6.1 b12.7 b18 b18.2 b19 b

Total Equity

11.7 b15.8 b19.1 b19.4 b20.5 b

Debt to Equity Ratio

0.6 x0.8 x1.2 x1.4 x

Debt to Assets Ratio

0.3 x0.4 x0.4 x0.5 x

Financial Leverage

1.9 x2.2 x2.7 x2.9 x3.4 x

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018

Cash

2 b6.4 b8.7 b6.2 b10.6 b7.4 b14 b6.3 b6.5 b9.8 b10.3 b8.7 b7.6 b

Accounts Receivable

2 b3.2 b3.4 b2.9 b4.8 b5.3 b6.1 b

Inventories

1.9 b2.1 b2.1 b1.9 b1.9 b2 b2 b1.9 b1.9 b1.9 b1.5 b1.4 b885 m

Current Assets

7 b13 b15.5 b12.6 b20.1 b18.1 b25.9 b19.3 b18.4 b21.4 b21.4 b28.6 b30.3 b

PP&E

1.1 b1.3 b1.4 b1.5 b1.8 b1.9 b2.1 b2.4 b2.6 b2.7 b2.9 b3 b3.4 b

Goodwill

1.2 b1.2 b1.2 b1.2 b1.2 b1.2 b1.2 b1.2 b1.2 b1.2 b1.2 b1.2 b4.2 b

Total Assets

22.5 b28.1 b31.2 b28.8 b38.3 b39.2 b50.6 b47.8 b50 b56.6 b57.7 b60.3 b65.4 b

Accounts Payable

1.4 b1.2 b1.2 b1.2 b1 b1.6 b1.2 b945 m1.1 b1.1 b944 m819 m711 m

Current Liabilities

4.9 b5.9 b6.2 b6.1 b7.4 b8.9 b9.4 b10.9 b10.4 b11.1 b8.3 b8.5 b10.7 b

Long-term debt

26.6 b

Total Debt

26.6 b

Additional Paid-in Capital

5.2 b5.7 b5.9 b2.1 b2.7 b285 m516 m632 m321 m616 m733 m1.6 b

Retained Earnings

5.7 b7.7 b10.2 b11.2 b13.9 b16 b17 b13 b14.9 b16.7 b19.6 b21.8 b19.2 b

Total Equity

16.6 b17.9 b14 b16.1 b17.4 b20.9 b23.1 b20.7 b

Financial Leverage

2.4 x2.8 x3.4 x3.1 x3.3 x2.8 x2.6 x3.2 x

Gilead Sciences Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

3.1 b12.1 b18.1 b13.5 b4.6 b

Depreciation and Amortization

233 m

Accounts Receivable

(315.3 m)(2.6 b)(1.4 b)1.2 b754 m

Inventories

(343.1 m)143 m(855 m)(488 m)(253 m)

Accounts Payable

(97.7 m)(289 m)226 m47 m(430 m)

Cash From Operating Activities

3.1 b12.8 b20.3 b16.7 b11.9 b

Cash From Investing Activities

(254.4 m)(1.8 b)(12.5 b)(12 b)(16.1 b)

Cash From Financing Activities

(2.5 b)(3 b)(5 b)(9.3 b)3.4 b

Interest Paid

238.3 m330 m529 m885 m1 b

Income Taxes Paid

1.1 b2.1 b3.1 b2.4 b3.3 b

Free Cash Flow

3.3 b13.4 b21.1 b17.4 b11.3 b

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018

Net Income

785.2 m2.2 b3.7 b2.7 b4.3 b8.8 b13.4 b3.6 b7.1 b10.4 b2.7 b5.8 b1.5 b

Depreciation and Amortization

75 m116 m42 m85 m129 m49 m103 m56 m

Accounts Receivable

(810 m)(1.6 b)(191 m)190 m770 m537 m118 m101 m

Inventories

(634 m)(659 m)(14 m)(97 m)(274 m)(5 m)(14 m)(14 m)

Accounts Payable

620 m288 m(239 m)(67 m)(115 m)(262 m)(399 m)(92 m)

Cash From Operating Activities

11.4 b15.5 b3.9 b8.9 b13.2 b2.9 b6.5 b2.3 b

Cash From Investing Activities

(5.9 b)(10 b)(2.1 b)(5.4 b)(9.3 b)307 m(3.9 b)4.4 b

Cash From Financing Activities

(8.1 b)(1.4 b)(8.4 b)(9.9 b)(7.1 b)(1.2 b)(2.1 b)(6.6 b)

Free Cash Flow

11.1 b14.9 b3.7 b8.5 b12.6 b2.8 b6.2 b2.1 b

Gilead Sciences Ratios

USDY, 2018

EV/EBIT

51.8 x

EV/CFO

49.1 x

EV/FCF

54.1 x

Financial Leverage

3.2 x
Report incorrect company information

Gilead Sciences Operating Metrics

FY, 2016

Countries

30

Facilities

5

Phase I Trials Products

3

Phase II Trials Products

12

Phase III Trials Products

6

Products

25
Report incorrect company information